{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:25:00Z","timestamp":1773923100661,"version":"3.50.1"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/qai.0b013e31819c291b","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T12:43:18Z","timestamp":1242909798000},"page":"499-505","source":"Crossref","is-referenced-by-count":116,"title":["Prevalence and Pathogenesis of Diabetes Mellitus in HIV-1 Infection Treated With Combined Antiretroviral Therapy"],"prefix":"10.1097","volume":"50","author":[{"given":"Katherine","family":"Samaras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-8-20210131","first-page":"1414","article-title":"Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections, Diabetes Care.","volume":"21","author":"King","year":"1998","journal-title":""},{"key":"R4-8-20210131","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults.","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R5-8-20210131","first-page":"S43","article-title":"Diagnosis and classification of diabetes mellitus.","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"R6-8-20210131","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1468-1293.2005.00273.x","article-title":"Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort.","volume":"6","author":"El-Sadr","year":"2005","journal-title":"HIV Med"},{"key":"R7-8-20210131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00042560-199801010-00007","article-title":"Severe hyperglycemia in an HIV clinic: preexisting versus drug-associated diabetes mellitus.","volume":"17","author":"Kilby","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R8-8-20210131","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med"},{"key":"R9-8-20210131","doi-asserted-by":"crossref","first-page":"587","DOI":"10.5694\/j.1326-5377.1996.tb138654.x","article-title":"Diabetes mellitus associated with pentamidine use in HIV-infected patients.","volume":"165","author":"Coyle","year":"1996","journal-title":"Med J Aust"},{"key":"R10-8-20210131","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/1056-8727(95)00111-5","article-title":"A pentamidine-treated acquired immunodeficiency syndrome patient associated with sudden onset diabetes mellitus and high tumor necrosis factor alpha level.","volume":"11","author":"Ubukata","year":"1997","journal-title":"J Diabetes Complications"},{"key":"R11-8-20210131","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00006676-199510000-00016","article-title":"Pentamidine-induced hyperglycemia and ketosis in acquired immunodeficiency syndrome.","volume":"11","author":"Lu","year":"1995","journal-title":"Pancreas"},{"key":"R12-8-20210131","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-127-10-199711150-00016","article-title":"Severe diabetes associated with protease inhibitor therapy.","volume":"127","author":"Visnegarwala","year":"1997","journal-title":"Ann Intern Med"},{"key":"R13-8-20210131","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/0003-4819-127-10-199711150-00017","article-title":"New-onset diabetes mellitus associated with use of protease inhibitor.","volume":"127","author":"Eastone","year":"1997","journal-title":"Ann Intern Med"},{"key":"R14-8-20210131","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease-inhibitor-associated hyperglycaemia.","volume":"350","author":"Dube","year":"1997","journal-title":"Lancet"},{"key":"R15-8-20210131","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance due to HIV protease inhibitors.","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R16-8-20210131","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Natural history, diagnosis and prediction of HIV protease inhibitor-induced lipodystrophy, hyperlipidaemia and diabetes mellitus.","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"R17-8-20210131","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R18-8-20210131","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc07-2013","article-title":"Incidence and risk factors for new-onset diabetes in HIV-infected patients: the data collection on adverse events of anti-HIV drugs (D:A:D) study.","volume":"31","author":"De Wit","year":"2008","journal-title":"Diabetes Care"},{"key":"R19-8-20210131","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","article-title":"An objective case definition of lipodystrophy in HIV-infected adults: a case control study.","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"R20-8-20210131","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00126334-200104150-00006","article-title":"Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy.","volume":"26","author":"Mulligan","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-8-20210131","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"R22-8-20210131","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00002030-200105040-00005","article-title":"Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection.","volume":"15","author":"van der Valk","year":"2001","journal-title":"AIDS"},{"key":"R23-8-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Pozniak AL, et al, and the 903 Study Group. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"R24-8-20210131","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/01.qai.0000137373.26438.18","article-title":"Case-control study of diabetes mellitus in HIV-infected patients.","volume":"37","author":"Yoon","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-8-20210131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/dc06-1075","article-title":"Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using international diabetes foundation and adult treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive peptide, and hypoadiponectinemia.","volume":"30","author":"Samaras","year":"2007","journal-title":"Diabetes Care"},{"key":"R26-8-20210131","first-page":"1088","article-title":"Prevalence and incidence of diabetes in HIV-infected minority patients on protease inhibitors.","volume":"97","author":"Salehian","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"R27-8-20210131","first-page":"557","article-title":"A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.","volume":"39","author":"Amorosa","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-8-20210131","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1086\/429824","article-title":"Disorders of glucose metabolism among HIV-infected women.","volume":"40","author":"Howard","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R29-8-20210131","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00126334-200303010-00009","article-title":"Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.","volume":"32","author":"Justman","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-8-20210131","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/QAD.0b013e32827038d0","article-title":"Antiretroviral therapy exposure and incidence of diabetes mellitus in the Womens Interagency HIV Study.","volume":"21","author":"Tien","year":"2007","journal-title":"AIDS"},{"key":"R31-8-20210131","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1742-1241.2004.00170.x","article-title":"Insulin resistance in chronic hepatitis C.","volume":"58","author":"Yazicioglu","year":"2004","journal-title":"Int J Clin Pract"},{"key":"R32-8-20210131","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00126334-200308150-00005","article-title":"The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons.","volume":"33","author":"Mehta","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R33-8-20210131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1086\/518619","article-title":"Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.","volume":"45","author":"Ledergerber","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R36-8-20210131","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome.","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R37-8-20210131","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The IDF consensus worldwide definition of the metabolic syndrome.","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"R38-8-20210131","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/diacare.28.1.132","article-title":"Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors.","volume":"28","author":"Jerico","year":"2005","journal-title":"Diabetes Care"},{"key":"R39-8-20210131","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/01.qai.0000243093.34652.41","article-title":"Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey).","volume":"43","author":"Jacobson","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R40-8-20210131","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1258\/095646207780132415","article-title":"Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy.","volume":"18","author":"Palacios","year":"2007","journal-title":"Int J STD AIDS"},{"key":"R41-8-20210131","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1097\/QAD.0b013e3282efad32","article-title":"Metabolic Syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infection.","volume":"21","author":"Wand","year":"2007","journal-title":"AIDS"},{"key":"R42-8-20210131","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkm475","article-title":"Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 (HIV) infection.","volume":"61","author":"Samaras","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R43-8-20210131","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","article-title":"Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.","volume":"51","author":"McGarry","year":"2002","journal-title":"Diabetes"},{"key":"R44-8-20210131","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of protease-inhibitor-associated syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance.","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"R45-8-20210131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1463-1326.2001.00146.x","article-title":"Antiretroviral therapy, insulin resistance and lipodystrophy.","volume":"3","author":"Gan","year":"2001","journal-title":"Diabetes Obes Metab"},{"key":"R46-8-20210131","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1017\/S0029665107005320","article-title":"Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD.","volume":"66","author":"Eckel","year":"2007","journal-title":"Proc Nutr Soc"},{"key":"R47-8-20210131","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc06-2484","article-title":"Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.","volume":"30","author":"Meigs","year":"2007","journal-title":"Diabetes Care"},{"key":"R48-8-20210131","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/dc06-0919","article-title":"Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study.","volume":"30","author":"Bonora","year":"2007","journal-title":"Diabetes Care"},{"key":"R49-8-20210131","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0026-0495(91)90059-6","article-title":"Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men.","volume":"40","author":"Hommes","year":"1991","journal-title":"Metabolism"},{"key":"R50-8-20210131","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","article-title":"Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.","volume":"16","author":"Noor","year":"2002","journal-title":"AIDS"},{"key":"R51-8-20210131","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/QAD.0b013e32826fbc54","article-title":"Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers.","volume":"21","author":"Lee","year":"2007","journal-title":"AIDS"},{"key":"R52-8-20210131","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/QAD.0b013e3282f33557","article-title":"Zidovudine\/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.","volume":"22","author":"Blumer","year":"2008","journal-title":"AIDS"},{"key":"R53-8-20210131","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy.","volume":"275","author":"Murata","year":"2000","journal-title":"J Biol Chem"},{"key":"R54-8-20210131","doi-asserted-by":"crossref","first-page":"55147","DOI":"10.1074\/jbc.M410826200","article-title":"A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity.","volume":"279","author":"Hertel","year":"2004","journal-title":"J Biol Chem"},{"key":"R55-8-20210131","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation and induces insulin resistance.","volume":"50","author":"Caron","year":"2001","journal-title":"Diabetes"},{"key":"R56-8-20210131","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/341489","article-title":"Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy.","volume":"35","author":"Dube","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R57-8-20210131","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1210\/jc.2002-021600","article-title":"Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices.","volume":"88","author":"Tong","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R58-8-20210131","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.2337\/diabetes.51.11.3163","article-title":"Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.","volume":"51","author":"Gan","year":"2002","journal-title":"Diabetes"},{"key":"R59-8-20210131","doi-asserted-by":"crossref","first-page":"E1666","DOI":"10.1152\/ajpendo.00550.2006","article-title":"Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults.","volume":"292","author":"Fleischman","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R60-8-20210131","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/429697","article-title":"In vivo, nucleoside reverse transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of mitochondrial DNA depletion.","volume":"191","author":"Mallon","year":"2005","journal-title":"J Infect Dis"},{"key":"R61-8-20210131","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/diabetes.52.4.918","article-title":"Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.","volume":"52","author":"Woerle","year":"2003","journal-title":"Diabetes"},{"key":"R62-8-20210131","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"R63-8-20210131","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1677\/joe.1.05620","article-title":"Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.","volume":"183","author":"Schutt","year":"2004","journal-title":"J Endocrinol"},{"key":"R64-8-20210131","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/diabetes.52.7.1695","article-title":"HIV protease inhibitors acutely impair glucose-stimulated insulin release.","volume":"52","author":"Koster","year":"2003","journal-title":"Diabetes"},{"key":"R65-8-20210131","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00126334-200012010-00004","article-title":"Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.","volume":"25","author":"Mynarcik","year":"2000","journal-title":"J Acquir Immunne Defic Syndr"},{"key":"R66-8-20210131","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.qai.0000159323.59250.83","article-title":"Increased cardiovascular disease risk indices in HIV-infected women.","volume":"39","author":"Dolan","year":"2005","journal-title":"J Aquir Immune Defic Syndr"},{"key":"R67-8-20210131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350300800102","article-title":"Adipocyte-derived hormone levels in HIV lipodystrophy.","volume":"8","author":"Kosmiski","year":"2003","journal-title":"Antivir Ther"},{"key":"R68-8-20210131","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00126334-200212150-00009","article-title":"Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution.","volume":"31","author":"Mynarcik","year":"2002","journal-title":"J Acquir Immunne Defic Syndr"},{"key":"R69-8-20210131","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients.","volume":"9","author":"Jan","year":"2004","journal-title":"Antivir Ther"},{"key":"R70-8-20210131","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/oby.2008.500","article-title":"Proinflammatory markers, insulin sensitivity and cardiometabolic risk factors in treated HIV-infection.","volume":"17","author":"Samaras","year":"2009","journal-title":"Obesity"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200904150-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T18:43:49Z","timestamp":1710355429000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200904150-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31819c291b","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}